Pfizer Ord (PFE) Shareholder Canal Insurance Company Upped Holding; Amazon.Com (AMZN) Stock Rose While Rosenblum Silverman Sutton S F Cut Stake by $672,448

Pfizer Inc. (NYSE:PFE) Logo

Canal Insurance Company increased its stake in Pfizer Ord (PFE) by 453.5% based on its latest 2018Q4 regulatory filing with the SEC. Canal Insurance Company bought 136,050 shares as the company’s stock declined 4.08% while stock markets rallied. The institutional investor held 166,050 shares of the health care company at the end of 2018Q4, valued at $7.25 million, up from 30,000 at the end of the previous reported quarter. Canal Insurance Company who had been investing in Pfizer Ord for a number of months, seems to be bullish on the $219.32 billion market cap company. The stock decreased 3.46% or $1.41 during the last trading session, reaching $39.51. About 26.72 million shares traded or 10.63% up from the average. Pfizer Inc. (NYSE:PFE) has risen 20.88% since April 17, 2018 and is uptrending. It has outperformed by 16.51% the S&P500. Some Historical PFE News: 15/03/2018 – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market to Reach Over US$ 3; 09/04/2018 – SOUTH AFRICA’S NEW MEDICINES REGULATOR SAYS CONSIDERING ASKING PHARMA COMPANIES TO PAY “BACKLOG FEE” TO SPEED UP DRUG APPROVALS; 08/03/2018 – Pfizer Says FDA Panel Votes In Favor of Expanding Use of Xeljanz; 23/03/2018 – GSK’s two-drug HIV regimen wins European panel approval; 30/03/2018 – Big deal – $ALNY -8.3% Don’t miss Watch out Alnylam/Ionis: Pfizer’s positive PhIII tafamidis data makes drug a new rival @BrittanyMeiling; 29/05/2018 – Roche: Study is on Tecentriq Plus Chemotherapy for Type of Lung Cancer; 16/04/2018 – BRISTOL-MYERS SQUIBB – IN PHASE 3 CHECKMATE -214 TRIAL, OPDIVO + YERVOY ALSO DELIVERED DURABLE RESPONSES, WITH HIGHER OBJECTIVE RESPONSE RATE VS SUNITINIB; 10/04/2018 – FOCUS-Lonza’s virus factory shows gene therapy’s Texas-sized promise; 16/05/2018 – PHASE lll IMPOWER150 STUDY SHOWED GENENTECH’S TECENTRIQ AND AVASTIN PLUS CARBOPLATIN AND PACLITAXEL HELPED PEOPLE WITH A SPECIFIC TYPE OF METASTATIC LUNG CANCER LIVE SIGNIFICANTLY LONGER COMPARED TO…; 04/04/2018 – STAT Plus: Pharmalittle: Will P&G buy the Pfizer consumer unit? China looks to boost generic production

Rosenblum Silverman Sutton S F Inc decreased its stake in Amazon.Com Inc (AMZN) by 4.57% based on its latest 2018Q4 regulatory filing with the SEC. Rosenblum Silverman Sutton S F Inc sold 448 shares as the company’s stock rose 1.10% with the market. The institutional investor held 9,351 shares of the consumer services company at the end of 2018Q4, valued at $14.05M, down from 9,799 at the end of the previous reported quarter. Rosenblum Silverman Sutton S F Inc who had been investing in Amazon.Com Inc for a number of months, seems to be less bullish one the $917.74 billion market cap company. The stock increased 0.11% or $2.09 during the last trading session, reaching $1865.13. About 1.98 million shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 13.57% since April 17, 2018 and is uptrending. It has outperformed by 9.20% the S&P500. Some Historical AMZN News: 03/04/2018 – Amazon builds tech’s largest in-house lobbying team; 02/04/2018 – Revolutionary Lotus 39 Hair Loss Treatment Debuts on Amazon; 01/05/2018 – Sabre announces strategic relationship with Amazon Web Services to accelerate the evolution of travel technology; 30/05/2018 – Amazon Expands Prime Benefit at Whole Foods Market to 12 Additional States and all Whole Foods Market 365 Stores; 05/04/2018 – Trump also criticizes Amazon and says the company is not on a level playing field; 09/03/2018 – AMAZON.COM INC AMZN.O : UBS RAISES TARGET PRICE TO $1760 FROM $1620; 30/04/2018 – The Curious Case of the Amazon Prime Price Hike: Fully Charged; 14/05/2018 – AMAZON IS SAID TO CHALLENGE GOOGLE, CRITEO WITH WEB ADS TOOL; 22/04/2018 – People think Amazon has the most positive impact on society out of any major tech company; 07/05/2018 – Snap Replaces Chief Financial Officer With Amazon Exec — MarketWatch

Investors sentiment increased to 1.55 in Q4 2018. Its up 0.37, from 1.18 in 2018Q3. It increased, as 93 investors sold AMZN shares while 536 reduced holdings. 184 funds opened positions while 793 raised stakes. 371.97 million shares or 42.70% more from 260.67 million shares in 2018Q3 were reported. Moreover, Hilltop Inc has 0.7% invested in Amazon.com, Inc. (NASDAQ:AMZN). Nikko Asset Management Americas invested 6.29% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Doheny Asset Mgmt Ca reported 731 shares. Dsm Capital Prtn Limited Liability Company reported 77,508 shares. 1,944 are held by Wendell David Assocs. Moreover, Vulcan Value Prtnrs Limited Liability has 3.52% invested in Amazon.com, Inc. (NASDAQ:AMZN). Duff & Phelps Invest Management Com holds 0.11% or 4,245 shares in its portfolio. Moreover, Ar Asset Mngmt has 0.24% invested in Amazon.com, Inc. (NASDAQ:AMZN). Archon Ltd Liability Co holds 5.24% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) for 13,983 shares. Jennison Limited Liability Corporation has invested 4.72% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Green Valley Investors Ltd Limited Liability Company reported 12.01% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Guyasuta Investment Advsrs Incorporated owns 910 shares or 0.17% of their US portfolio. Sterling Glob Strategies Ltd Liability Company has 122 shares. Country Club Trust Na holds 0.2% in Amazon.com, Inc. (NASDAQ:AMZN) or 990 shares. Westover Capital Advisors Limited Liability Corporation invested in 2,224 shares or 2.09% of the stock.

Since October 29, 2018, it had 0 buys, and 10 selling transactions for $50.29 million activity. 1,929 shares were sold by Zapolsky David, worth $3.02 million on Thursday, November 15. Reynolds Shelley sold $687,447 worth of stock. 181 shares were sold by Huttenlocher Daniel P, worth $285,960. On Tuesday, November 20 WILKE JEFFREY A sold $1.85M worth of Amazon.com, Inc. (NASDAQ:AMZN) or 1,230 shares. Olsavsky Brian T also sold $3.21M worth of Amazon.com, Inc. (NASDAQ:AMZN) shares. Shares for $2.70 million were sold by Jassy Andrew R on Thursday, November 15.

Rosenblum Silverman Sutton S F Inc, which manages about $291.11M and $219.36M US Long portfolio, upped its stake in Fidelity National Information Services I (NYSE:FDX) by 46,524 shares to 62,317 shares, valued at $6.39 million in 2018Q4, according to the filing. It also increased its holding in Cactus Inc. by 46,405 shares in the quarter, for a total of 66,855 shares, and has risen its stake in Celanese Corp. (NYSE:CAT).

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Benzinga.com which released: “Amazon.com, Inc. (NASDAQ:AMZN) – Volkswagen Partners With Amazon Subsidiary To Improve Operational Efficiency – Benzinga” on March 27, 2019, also Nasdaq.com with their article: “Will Alphabet’s Big Bet on Google Cloud Be Enough? – Nasdaq” published on April 16, 2019, Seekingalpha.com published: “Amazon launches MLB.TV Prime channel – Seeking Alpha” on March 20, 2019. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: Nasdaq.com and their article: “EBAY vs. AMZN: Which Stock Should Value Investors Buy Now? – Nasdaq” published on March 20, 2019 as well as Nasdaq.com‘s news article titled: “Amazon (AMZN) Gains As Market Dips: What You Should Know – Nasdaq” with publication date: April 15, 2019.

Analysts await Amazon.com, Inc. (NASDAQ:AMZN) to report earnings on April, 25. They expect $4.67 EPS, up 42.81% or $1.40 from last year’s $3.27 per share. AMZN’s profit will be $2.30B for 99.85 P/E if the $4.67 EPS becomes a reality. After $6.04 actual EPS reported by Amazon.com, Inc. for the previous quarter, Wall Street now forecasts -22.68% negative EPS growth.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: 247Wallst.com which released: “5 Must-Own Merrill Lynch Income Portfolio High-Dividend Stocks – 24/7 Wall St.” on March 25, 2019, also Forbes.com with their article: “How Important Is Oncology For Pfizer? – Forbes” published on March 18, 2019, 247Wallst.com published: “Pfizer Moves Over Half a Billion for Wilson Disease Treatment – 24/7 Wall St.” on March 20, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer Steps Further In The Door For Gene Therapies – Seeking Alpha” published on March 22, 2019 as well as 247Wallst.com‘s news article titled: “Pfizer and Apple Remain Most Shorted Dow Stocks – 24/7 Wall St.” with publication date: March 27, 2019.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart